Enter a keyword or phrase to search all pages in this section:


Advanced search

Archive:

Looking for a previously published document in this section?

Recall of Octagam intravenous Immunoglobulin 5% and 10% due to thromboembolic events

A Class 2 Drug Alert has been issued to recall all remaining stock of Octagam 5% and 10% intravenous Immunoglobulin (IVIG) Solutions for Infusion (link to Drug Alert). This is because of an unexpected increase in reported cases of thromboembolic events (unwanted blood clots in the arteries or veins).

Healthcare professionals are advised:

  • do not use any unused vials of Octagam 5% and Octagam 10%
  • quarantine and return all unused stock with immediate effect and seek alternative supplies of intravenous immunoglobulin
  • be extra vigilant for signs of a thromboembolic event in patients who have very recently received Octagam
  • to report any suspected thromboembolic events that have occurred in association with Octagam on a Yellow Card at www.yellowcard.gov.uk  

Patients should speak to their doctor or pharmacist if they have any questions or concerns.

For further information please see the Drug Alert:

Class 2 Drug Alert (action within 48 hours): Octapharma Limited - Octagam 5% Solution for Infusion (50mg/ml) and Octagam 10% Solution for Infusion (100mg/ml) - EL(10)A/20

Page last modified: 27 September 2010